Tianfeng Yang

1.6k total citations
69 papers, 1.3k citations indexed

About

Tianfeng Yang is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Tianfeng Yang has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Biomedical Engineering and 10 papers in Materials Chemistry. Recurrent topics in Tianfeng Yang's work include Nanoplatforms for cancer theranostics (9 papers), Axon Guidance and Neuronal Signaling (8 papers) and Solar Thermal and Photovoltaic Systems (7 papers). Tianfeng Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Axon Guidance and Neuronal Signaling (8 papers) and Solar Thermal and Photovoltaic Systems (7 papers). Tianfeng Yang collaborates with scholars based in China, Pakistan and Italy. Tianfeng Yang's co-authors include Yanmin Zhang, Gang Xiao, Man Zhu, Dongdong Zhang, Bingling Dai, Mingjiang Ni, Dong Ni, Weina Ma, Runze Yu and Kefa Cen and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Tianfeng Yang

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianfeng Yang China 23 421 237 186 166 161 69 1.3k
Kexin Yang China 18 329 0.8× 120 0.5× 157 0.8× 96 0.6× 90 0.6× 58 1.1k
Aiqin Li China 23 527 1.3× 224 0.9× 274 1.5× 77 0.5× 115 0.7× 97 1.7k
Han Bao China 19 354 0.8× 213 0.9× 171 0.9× 40 0.2× 122 0.8× 66 1.0k
Xiaolan Yang China 24 755 1.8× 179 0.8× 383 2.1× 62 0.4× 57 0.4× 158 1.8k
Ke Zheng China 18 200 0.5× 438 1.8× 342 1.8× 66 0.4× 75 0.5× 56 1.0k
Yanhua Fan China 22 467 1.1× 179 0.8× 252 1.4× 39 0.2× 86 0.5× 95 1.4k
Dongxiao Yang China 20 315 0.7× 225 0.9× 242 1.3× 164 1.0× 41 0.3× 69 1.3k
Seung Hoon Choi South Korea 19 385 0.9× 117 0.5× 243 1.3× 61 0.4× 119 0.7× 90 1.4k
Yufei Chen China 20 447 1.1× 244 1.0× 180 1.0× 44 0.3× 105 0.7× 62 1.5k
Xiaoyu Fan China 23 699 1.7× 223 0.9× 570 3.1× 71 0.4× 177 1.1× 89 1.8k

Countries citing papers authored by Tianfeng Yang

Since Specialization
Citations

This map shows the geographic impact of Tianfeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianfeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianfeng Yang more than expected).

Fields of papers citing papers by Tianfeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianfeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianfeng Yang. The network helps show where Tianfeng Yang may publish in the future.

Co-authorship network of co-authors of Tianfeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Tianfeng Yang. A scholar is included among the top collaborators of Tianfeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianfeng Yang. Tianfeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Tianfeng, Bo Huang, Cheng Jiang, et al.. (2025). Mechanical properties and mechanisms of soda residue and fly ash stabilized soil. Scientific Reports. 15(1). 1103–1103. 4 indexed citations
3.
Zhao, Xiaoqing, Cheng Jiang, Bo Huang, et al.. (2025). Soda residue-fly ash-based controlled low-strength material: Mechanical properties and microstructural mechanisms. Construction and Building Materials. 504. 144641–144641.
4.
Zhao, Xiaoqing, et al.. (2025). Disintegration characteristics and microscopic mechanism of soda residue-fly ash stabilized clay. Journal of Building Engineering. 107. 112676–112676. 1 indexed citations
5.
Yang, Tianfeng, Suyu Zhang, Kun Nie, et al.. (2025). ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion. Drug Resistance Updates. 82. 101274–101274. 2 indexed citations
6.
Yang, Tianfeng, Suyu Zhang, Kun Nie, et al.. (2025). WWOX-mediated p53/SAT1 and NRF2/FPN1 axis contribute to toosendanin-induced ferroptosis in hepatocellular carcinoma. Biochemical Pharmacology. 233. 116790–116790. 2 indexed citations
7.
Yang, Tianfeng, et al.. (2024). Characteristics of Molten Salt Gasification of Waste PVC. Processes. 12(2). 306–306. 1 indexed citations
9.
10.
Yang, Tianfeng, Runze Yu, Cheng Cheng, et al.. (2023). Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR. Journal of Translational Medicine. 21(1). 597–597. 23 indexed citations
11.
Ma, Weina, Man Zhu, Bo Wang, et al.. (2022). Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 4. Molecular Oncology. 16(14). 2747–2765. 5 indexed citations
12.
Yang, Tianfeng, et al.. (2022). Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities. Critical Reviews in Oncology/Hematology. 180. 103858–103858. 12 indexed citations
13.
Dai, Bingling, Mengying Fan, Hanbing Cao, et al.. (2022). Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cells. Phytomedicine. 103. 154249–154249. 18 indexed citations
14.
Zhu, Man, Qing Wu, Qi Su, et al.. (2020). Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma. Cell Death and Disease. 11(8). 632–632. 28 indexed citations
15.
Zhu, Man, Xianpeng Shi, Qi Su, et al.. (2020). Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner. Pharmacological Research. 158. 104868–104868. 54 indexed citations
16.
Shi, Xianpeng, Man Zhu, Tianfeng Yang, et al.. (2019). Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways. Food and Chemical Toxicology. 136. 110960–110960. 32 indexed citations
17.
Yang, Tianfeng, Yuxin Cui, Runze Yu, et al.. (2019). <p>pH-sensitive doxorubicin-loaded polymeric nanocomplex based on &beta;-cyclodextrin for liver cancer-targeted therapy</p>. International Journal of Nanomedicine. Volume 14. 1997–2010. 31 indexed citations
19.
Yang, Liu, Man Zhu, Yuan Kang, Tianfeng Yang, & Weina Ma. (2018). Investigation of the binding characteristics between ligands and epidermal growth factor receptor by cell membrane chromatography. Journal of Molecular Recognition. 31(6). e2701–e2701. 9 indexed citations
20.
Zhu, Man, Yuxin Cui, Liu Yang, et al.. (2018). Ephrin type-B receptor 4 affinity chromatography: An effective and rapid method studying the active compounds targeting Ephrin type-B receptor 4. Journal of Chromatography A. 1586. 82–90. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026